Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis
Clinical trial NCT04375514 · TERMINATED
Trial details
- NCT number
- NCT04375514
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-30
- Primary completion
- 2021-05-09
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.